Bausch Health (BHC)
(Delayed Data from NYSE)
$6.01 USD
-0.19 (-3.06%)
Updated Aug 12, 2022 04:00 PM ET
5-Strong Sell of 5 5
A Value F Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 37% (94 out of 252)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.57 | 1.42 | 9.99 |
Current Quarter Estimate | 1.04 | 1.25 | 57.00 |
Year Ago Quarter Estimate | 1.14 | -4.28 | 52.05 |
Next Quarter Estimate | 1.16 | 1.37 | 51.00 |
Next Year Estimate | 3.98 | 7.08 | 235.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -23.54 | -2.20 | 8.62 |
Next Year | 16.72 | 6.70 | 3.91 |
Last 5 Years | -5.10 | 6.80 | 13.40 |
Next 5 Years | 20.00 | 12.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 1.63 | 1.64 |
Price/Book (MRQ) | 8.58 | 1.33 |
Price/Cash Flow (MRFY) | 0.67 | 13.51 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 0.52% | 1.15% |
Return on Equity (TTM) | -9,431.58% | 12.79% |
Debt to Equity (MRQ) | 85.63 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.